Status:
RECRUITING
Woodcasting Versus Thermoplast Splint in CMC Arthroplasty
Lead Sponsor:
Foundation for Orthopaedic Research and Education
Conditions:
Carpometacarpal (CMC) Joint Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a prospective, randomized, nonblinded trial to evaluate patient preference in splints after having a carpometacarpal arthroplasty.
Detailed Description
Patients undergoing carpometacarpal arthroplasty will be randomized into the woodcast or thermoplast splint after their surgery to see which is preferred using compliance and surveys.
Eligibility Criteria
Inclusion
- Patients over the age of 18 years old.
- Intact Medical Decision Making
- Eligible for Surgical Intervention
- Willing to comply with all aspects of the treatment and evaluation schedule over 6 weeks
Exclusion
- Pregnant Women
- Deemed Unsuitable by Principal Investigator
Key Trial Info
Start Date :
October 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06876350
Start Date
October 3 2024
End Date
June 30 2025
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Orthopaedic Institute
Tampa, Florida, United States, 33637